List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 56 studies with search of: Carnitine AND NOT Acetyl-L-carnitine
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Evaluation of Cilostazol in Combination With L-Carnitine
Conditions: Peripheral Vascular Disease;   Intermittent Claudication;   Peripheral Arterial Disease
Interventions: Dietary Supplement: Levocarnitine tartrate;   Drug: cilostazol
2 Completed Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia
Condition: β-Thalassemia Intermedia
Interventions: Drug: hydroxyurea;   Drug: L-carnitine and hydroxyurea;   Drug: hydroxyurea and magnesium chloride;   Drug: hydroxyurea,L-carnitine and magnesium chloride
3 Completed Early Administration of L-carnitine in Hemodialysis Patients
Conditions: Complication of Hemodialysis;   Hyperthyroidism Treated or Under Control
Intervention: Drug: L-Carnitine
4 Not yet recruiting L-carnitine to Treat Fatigue Associated With Crohn's Disease
Conditions: Crohn's Disease;   Fatigue
Interventions: Dietary Supplement: L-carnitine;   Other: Placebo
5 Suspended L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)
Condition: Pancreatic Carcinoma
Interventions: Dietary Supplement: L-Carnitine;   Dietary Supplement: Placebo
6 Enrolling by invitation Carnitine as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Methylphenidate+placebo;   Drug: methylphenidate+carnitine
7 Recruiting The Effects of L-carnitine on Fatigue in Spinal Cord Injury
Condition: Spinal Cord Injury (SCI)
Intervention: Drug: L-Carnitine
8 Unknown † Oral Carnitine for Cramps in Pregnancy
Condition: Muscle Cramp
Interventions: Dietary Supplement: L-Carnitine;   Dietary Supplement: Placebo
9 Unknown † Carnitine Levels and Carnitine Supplementation in Type I Diabetes
Conditions: Diabetes Mellitus, Type I;   Hypoglycemia
Intervention: Drug: Carnitine (drug)
10 Completed Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
Condition: Heart Failure
Intervention: Drug: L-carnitine
11 Completed
Has Results 		Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Interventions: Drug: Valproic Acid and Levocarnitine;   Drug: Placebo
12 Completed Propionyl-L-Carnitine in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Propionyl-L-Carnitine;   Drug: Placebo
13 Unknown † L-Carnitine as an Osmo-Metabolic Agent for Peritoneal Dialysis
Condition: End-Stage Renal Disease
Intervention: Drug: L-Carnitine
14 Completed
Has Results 		L-Carnitine in Peritoneal Dialysis
Condition: End-Stage Renal Disease
Intervention: Drug: L-carnitine
15 Unknown † Effects of L-Carnitine on Postprandial Clearance of Triglyceride-Rich Lipoproteins in HIV Patients on HAART
Conditions: Hyperlipidemia;   HIV Infections
Interventions: Dietary Supplement: L-carnitine;   Other: placebo
16 Recruiting Effects of Parenteral L-carnitine Supplementation in Premature Neonates
Condition: Prematurity
Interventions: Drug: Parenteral L-carnitine supplementation;   Drug: Parenteral supplementation with sterile water
17 Unknown † Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Conditions: End Stage Renal Disease;   Insulin Resistance
Interventions: Drug: PD solution;   Drug: PD solution containing L-carnitine
18 Unknown † Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Conditions: End Stage Renal Disease;   Diabetes
Interventions: Drug: PD Solution;   Drug: PD solution containing L-carnitine
19 Completed Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients
Condition: Complication of Hemodialysis
Interventions: Drug: L-carnitine;   Drug: placebo
20 Active, not recruiting Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART
Conditions: HIV Infections;   Hyperlipidemia;   Exercise
Intervention: Dietary Supplement: l-carnitine

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services